ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Rejection"

  • 2016 American Transplant Congress

    TNT009 and Its Parental Mouse Monoclonal Antibody TNT003 Target Complement Component C1s and Effectively Block Alloantibody-Induced Classical Complement Pathway Activation – The Preclinical Experience.

    M. Wahrmann,1 J. Mühlbacher,1 H. Regele,1 F. Eskandary,1 J. Gilbert,2 S. Panicker,2 G. Böhmig.1

    1VIETAC Laboratories, Medical University of Vienna, Vienna, Austria; 2True North Therapeutics, Inc., South San Francisco, CA.

    Introduction. Considering the key role of the classical complement pathway as a trigger of inflammation and injury in antibody-mediated rejection (ABMR), targeted classical pathway inhibition…
  • 2016 American Transplant Congress

    Effect of Inflammation on Concentration of Intracellular Tacrolimus.

    E. Bae,1 S. Yang,2 S. Han,1 J.-Y. Park,1 H. Lee,1 Y. Kim.1

    1Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea; 2Kidney Research Institute, Seoul National University, Seoul, Republic of Korea.

    Background: The use of calcineurin inhibitors improved the outcome for transplant recipients. However, acute rejection (AR) and infection remained still an unsolved problem. We evaluated…
  • 2016 American Transplant Congress

    Early Post-Transplant Patient, Graft Survival and Rejection Rates Under KAS.

    A. Kucheryavaya, D. Stewart, D. Klassen.

    UNOS, Richmond.

    Background: KAS, implemented on 12/4/14, resulted in changes in recipient, donor/recipient and tx characteristics that have the potential to affect post-tx outcomes.Data and Methods: We…
  • 2016 American Transplant Congress

    Better Long-Term Renal Function with Lower Incidence of Acute Rejection and Lower CMV Infection in Renal Transplant Patients Treated with a Combination of Tacrolimus and Everolimus.

    G. Spagnoletti, M. Salerno, V. Bianchi, N. Silvestrini, F. Apponi, J. Romagnoli, F. Citterio.

    Surgery - Renal Transplant Unit, Università Cattolica del Sacro Cuore, Rome, Italy.

    Introduction. Recent clinical trials have shown that the combination of CNIs with Everolimus (EVE) allows CNIs minimization, which may positively impact on chronic nephrotoxicity. Aim…
  • 2016 American Transplant Congress

    Treatment of Hepatitis C Viral Infection with Novel Direct Acting Antivirals in Kidney Transplant Recipients – Single Center Experience.

    K. Hatahet,1 M. Ghanta,1 A. Gillespie,1 I. Lee,1 H. El-Halawany,2 K. Qureshi,2 K. Lau,3 S. Karhadkar,3 A. Di Carlo,3 S. Constantinescu,1 S. Rao.1

    1Nephrology, Temple University, Phildelphia, PA; 2Hepatology, Temple University, Philadelphia, PA; 3Surgery, Temple University, Philadelphia, PA.

    Kidney transplant recipients (KTRs) with Hepatitis C virus infection (HCV+ve) have higher proteinuria and inferior patient and graft survival compared to HCV negative KTRs. Due…
  • 2016 American Transplant Congress

    Post-Transplant T-Cell Alloreactive Perturbation Precedes the Advent of Humoral Immunity in Kidney Transplant Patients.

    E. Crespo,1 S. Luque,1 J. Cruzado,2 E. Melilli,2 J. Grinyo,2 M. Lucia,1 O. Bestard.2

    1Experimental Nephrology Laboratory, IDIBELL, Barcelona, Spain; 2Kidney Transplant Unit, Bellvitge University Hospital, Barcelona, Spain.

    Subclinical inflammation in kidney allografts is associated with worse outcome and the activation of humoral alloimmunity. Surveillance allograft biopsies are an accurate tool to diagnose…
  • 2016 American Transplant Congress

    Molecular Diagnosis of Antibody-Mediated Rejection in Routine Formalin-Fixed Paraffin-Embedded Nonhuman Primate Renal Allograft Biopsies.

    B. Adam,1 I. Rosales,2 T. Oura,2 R. Smith,2 A. Cosimi,2 T. Kawai,2 R. Colvin,2 M. Mengel.1

    1University of Alberta, Edmonton, Canada; 2Harvard Medical School and Massachusetts General Hospital, Boston.

    Background: In 2013, the Banff classification proposed molecular testing as an adjunct for the diagnosis of antibody-mediated rejection (ABMR) in renal allografts. We analyzed whether…
  • 2016 American Transplant Congress

    Recipient Age and KDPI Are Potent Predictors of Early Acute Rejection in the Modern Era of Deceased Donor Kidney Transplantation.

    D. Keith, G. Vranic, A. Nishio Lucar.

    Medicine, University of Virginia, Charlottesville, VA.

    The rate of acute rejection in the first six months after deceased donor (DD) kidney transplant is about 10% in the modern era of immunosuppression.…
  • 2016 American Transplant Congress

    A Quantitative CD45 Assay May Improve Diagnostic Accuracy of the Diagnosis of Acute Cellular Rejection in Transplant Kidney Biopsies.

    L. Laszik, S. Bowman, V. Walavalkar, F. Vincenti, Z. Laszik.

    UCSF, San Francisco.

    Purpose: We have previously shown that the total inflammatory load in transplant kidney biopsies (TxBx) can be determined with a high degree of accuracy using…
  • 2016 American Transplant Congress

    How Tacrolimus Variability Affects Donor Specific Antibodies, Rejection and Outcome After Kidney Transplantation.

    S. Papachristos, A. John Velvet, A. Summers, A. Tavakoli, R. Dhanda, R. Pararajasingam, B. Forgacs.

    Manchester Transplantation Unit, Manchester Royal Infirmary Central Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom.

    Purpose:To investigate the effect of tacrolimus(tac) variability on the development of Donor Specific Antibodies(DSA),rejection and outcome in relation to Age, Gender, Ethnicity and Body Mass…
  • « Previous Page
  • 1
  • …
  • 132
  • 133
  • 134
  • 135
  • 136
  • …
  • 172
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences